NURELIN Trademark

Trademark Overview

On Tuesday, September 8, 2009, a trademark application was filed for NURELIN with the United States Patent and Trademark Office. The USPTO has given the NURELIN trademark a serial number of 77821907. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2013. This trademark is owned by Adamas Pharmaceuticals, Inc.. The NURELIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of nervous system disorders
nurelin

General Information

Serial Number77821907
Word MarkNURELIN
Filing DateTuesday, September 8, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2010

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of nervous system disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 11, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAdamas Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameAdamas Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Tuesday, May 28, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 27, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, March 8, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 27, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, September 20, 2012EXTENSION 5 GRANTED
Tuesday, September 18, 2012EXTENSION 5 FILED
Tuesday, September 18, 2012TEAS EXTENSION RECEIVED
Saturday, May 26, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, May 25, 2012EXTENSION 4 GRANTED
Friday, April 20, 2012EXTENSION 4 FILED
Friday, April 20, 2012TEAS EXTENSION RECEIVED
Wednesday, December 7, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 7, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 28, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, October 27, 2011EXTENSION 3 GRANTED
Monday, October 24, 2011EXTENSION 3 FILED
Monday, October 24, 2011TEAS EXTENSION RECEIVED
Thursday, April 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, April 20, 2011EXTENSION 2 GRANTED
Friday, April 15, 2011EXTENSION 2 FILED
Wednesday, April 20, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 15, 2011TEAS EXTENSION RECEIVED
Thursday, October 28, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, October 26, 2010EXTENSION 1 GRANTED
Tuesday, October 26, 2010EXTENSION 1 FILED
Tuesday, October 26, 2010TEAS EXTENSION RECEIVED
Tuesday, April 27, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 2, 2010PUBLISHED FOR OPPOSITION
Wednesday, January 13, 2010NOTICE OF PUBLICATION
Tuesday, December 29, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 29, 2009ASSIGNED TO LIE
Wednesday, December 9, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 9, 2009ASSIGNED TO EXAMINER
Friday, September 11, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 11, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

nurelin system disorders nervous treatment preparations pharmaceutical